403 related articles for article (PubMed ID: 21531588)
41. Patient-reported outcomes 5-8 years after ultrasound-guided foam sclerotherapy for varicose veins.
Darvall KA; Bate GR; Bradbury AW
Br J Surg; 2014 Aug; 101(9):1098-104. PubMed ID: 24962055
[TBL] [Abstract][Full Text] [Related]
42. Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy - A prospective, observational study of 8056 treatments.
Davies HO; Watkins M; Oliver R; Berhane S; Bradbury AW
Phlebology; 2022 Mar; 37(2):97-104. PubMed ID: 34657519
[TBL] [Abstract][Full Text] [Related]
43. Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins: a prospective randomised study.
Figueiredo M; Araújo S; Barros N; Miranda F
Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):758-63. PubMed ID: 19744867
[TBL] [Abstract][Full Text] [Related]
44. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
[TBL] [Abstract][Full Text] [Related]
45. Recovery after ultrasound-guided foam sclerotherapy compared with conventional surgery for varicose veins.
Darvall KA; Bate GR; Adam DJ; Bradbury AW
Br J Surg; 2009 Nov; 96(11):1262-7. PubMed ID: 19847864
[TBL] [Abstract][Full Text] [Related]
46. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
47. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
Kölbel T; Hinchliffe RJ; Lindblad B
Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
[TBL] [Abstract][Full Text] [Related]
48. Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.
Shadid N; Ceulen R; Nelemans P; Dirksen C; Veraart J; Schurink GW; van Neer P; vd Kley J; de Haan E; Sommer A
Br J Surg; 2012 Aug; 99(8):1062-70. PubMed ID: 22627969
[TBL] [Abstract][Full Text] [Related]
49. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial.
Bountouroglou DG; Azzam M; Kakkos SK; Pathmarajah M; Young P; Geroulakos G
Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):93-100. PubMed ID: 16233981
[TBL] [Abstract][Full Text] [Related]
50. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
Ukritmanoroat T
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
[TBL] [Abstract][Full Text] [Related]
51. Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux.
Chapman-Smith P; Browne A
Phlebology; 2009 Aug; 24(4):183-8. PubMed ID: 19620701
[TBL] [Abstract][Full Text] [Related]
52. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
Baeshko A; Shestak N; Korytko S
Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
[TBL] [Abstract][Full Text] [Related]
53. Ultrasound-guided catheter-directed foam sclerotherapy can be safely applied for the treatment of great saphenous varicose veins in elderly patients.
Kahraman N; Özsin KK
Vascular; 2020 Oct; 28(5):597-603. PubMed ID: 32281494
[TBL] [Abstract][Full Text] [Related]
54. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
[TBL] [Abstract][Full Text] [Related]
55. Single-center experience with foam sclerotherapy without ultrasound guidance for treatment of varicose veins.
Uurto I; Hannukainen J; Aarnio P
Dermatol Surg; 2007 Nov; 33(11):1334-9; discussion 1339. PubMed ID: 17958585
[TBL] [Abstract][Full Text] [Related]
56. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
Fabi SG; Peterson JD; Goldman MP; Guiha I
Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
[TBL] [Abstract][Full Text] [Related]
57. Patients' expectations before and satisfaction after ultrasound guided foam sclerotherapy for varicose veins.
Darvall KA; Bate GR; Sam RC; Adam DJ; Silverman SH; Bradbury AW
Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):642-7. PubMed ID: 19740684
[TBL] [Abstract][Full Text] [Related]
58. Foam sclerotherapy.
Alder G; Lees T
Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
[TBL] [Abstract][Full Text] [Related]
59. Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?
Gillet JL; Lausecker M; Sica M; Guedes JM; Allaert FA
Phlebology; 2014 Oct; 29(9):600-7. PubMed ID: 23864534
[TBL] [Abstract][Full Text] [Related]
60. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
